Accendra Health (ACH) CFO surrenders shares for tax withholding

Rhea-AI Filing Summary

Accendra Health EVP & CFO Jonathan A. Leon reported a small share disposition related to taxes rather than an open-market trade. On May 15, 2026, he surrendered 1,770 shares of Common Stock at $3.04 per share to cover tax withholding tied to vesting of restricted stock. After this tax-withholding transaction, he directly held 290,533 shares of Accendra Health common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Leon Jonathan A

Role EVP & CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,770	$3.04	$5K

Holdings After Transaction: Common Stock — 290,533 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares surrendered for tax withholding: 1,770 shares Price per share for tax withholding: $3.04 per share Shares held after transaction: 290,533 shares

3 metrics

Shares surrendered for tax withholding 1,770 shares Common Stock, transaction code F

Price per share for tax withholding $3.04 per share Value used for 1,770 surrendered shares

Shares held after transaction 290,533 shares Direct ownership by EVP & CFO after May 15, 2026

Key Terms

tax withholding obligations, restricted stock, tax-withholding disposition

3 terms

tax withholding obligations financial

"satisfy tax withholding obligations in connection with vesting of restricted stock"

restricted stock financial

"in connection with vesting of restricted stock granted to the Reporting Person"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leon Jonathan A

(Last) (First) (Middle)

ACCENDRA HEALTH, INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		F		1,770(1)	D	$3.04	290,533	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

	Jonathan A. Leon, by Rosemarie W. France POA	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Accendra Health (ACH) report for its CFO?

Accendra Health’s EVP & CFO Jonathan A. Leon surrendered 1,770 common shares to the company to cover tax withholding on vested restricted stock, rather than selling in the open market. After this routine tax transaction, he directly held 290,533 Accendra Health shares.

Was the Accendra Health (ACH) CFO’s Form 4 transaction an open-market sale?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Jonathan A. Leon surrendered 1,770 shares back to Accendra Health to satisfy tax obligations triggered by restricted stock vesting, a common administrative step for equity compensation.

How many Accendra Health (ACH) shares did the CFO surrender for taxes?

The CFO surrendered 1,770 shares of Accendra Health common stock at $3.04 per share. These shares were delivered to the company specifically to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock awards.

How many Accendra Health (ACH) shares does the CFO hold after this Form 4?

Following the tax-withholding disposition, EVP & CFO Jonathan A. Leon directly holds 290,533 Accendra Health common shares. This figure reflects his position after surrendering 1,770 shares to the company to cover taxes tied to restricted stock vesting.

What does transaction code “F” mean in the Accendra Health (ACH) Form 4?

Transaction code “F” on this Form 4 indicates shares were used to pay tax liabilities or exercise costs. Here, 1,770 shares of Accendra Health common stock were surrendered to satisfy tax withholding on vested restricted stock granted to the reporting officer.